惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
WordPress大学
WordPress大学
aimingoo的专栏
aimingoo的专栏
博客园 - 聂微东
M
MIT News - Artificial intelligence
Microsoft Security Blog
Microsoft Security Blog
云风的 BLOG
云风的 BLOG
Google DeepMind News
Google DeepMind News
Apple Machine Learning Research
Apple Machine Learning Research
H
Hackread – Cybersecurity News, Data Breaches, AI and More
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
O
OpenAI News
N
News and Events Feed by Topic
TaoSecurity Blog
TaoSecurity Blog
有赞技术团队
有赞技术团队
cs.AI updates on arXiv.org
cs.AI updates on arXiv.org
MyScale Blog
MyScale Blog
酷 壳 – CoolShell
酷 壳 – CoolShell
Hacker News: Ask HN
Hacker News: Ask HN
Help Net Security
Help Net Security
爱范儿
爱范儿
W
WeLiveSecurity
V2EX - 技术
V2EX - 技术
Forbes - Security
Forbes - Security
Hacker News - Newest:
Hacker News - Newest: "LLM"
SecWiki News
SecWiki News
A
About on SuperTechFans
Cloudbric
Cloudbric
N
Netflix TechBlog - Medium
博客园 - 司徒正美
S
Security @ Cisco Blogs
Martin Fowler
Martin Fowler
Schneier on Security
Schneier on Security
I
InfoQ
Engineering at Meta
Engineering at Meta
Google Online Security Blog
Google Online Security Blog
T
Troy Hunt's Blog
Latest news
Latest news
N
News and Events Feed by Topic
Security Archives - TechRepublic
Security Archives - TechRepublic
Spread Privacy
Spread Privacy
NISL@THU
NISL@THU
B
Blog
L
LINUX DO - 最新话题
K
KPMG report finds enterprise disconnect between AI and its ROI | CIO
V
V2EX
J
Java Code Geeks
N
News | PayPal Newsroom
T
Tor Project blog
The GitHub Blog
The GitHub Blog

Stocks Fundamentals Analysis India | The HinduBusinessLine

Who Am I? June 21, 2026 Shyam Metalics: What Should Investors Do? Turtlemint Fintech Solutions IPO: Should You Subscribe? Covers for Cancer Treatment Wonderla, V-Guard, Havells, Voltas, UBL, Blue Star, Emami: Hot Summer, Cold Stocks? Why Buy This Luxury Hotel on Dips Who Am I? June 14, 2026 Polycab India: What Should Investors Do? Who Am I? June 7, 2026 Cipla: Tonic For The Patient Investor JSW Steel: Will plans to double capacity boost stock price? Emami stock: Why this FMCG stock is a buy near its 52-week low Who Am I? May 31, 2026 Medanta: What Should Investors Do? Should investors buy HDFC Bank now? SpaceX IPO and the Big Bang Bubble Who Am I? May 24, 2026 Simply Put: Interest Coverage Ratio Who Am I? May 17, 2026 What They Say on Their India Plans SRF: On The Road to Recovery Godrej Agrovet Accumulate Call Palm Oil Animal Nutrition Outlook The Ramco Cements: What Should Investors Do? Nifty 50, Nifty 500: PE multiples can be the same number yet poles apart SAMHI Hotels stock call: Accumulate on dips What They Say on Their India Plans Who Am I? May 10, 2026 Who Am I? May 3, 2026 What They Say on Their India Plans Wait for the fog to clear first! Steel Authority of India: With SAIL shares at a 15-year high, what should investors do? Sun Pharma-Organon deal: Outlook is mixed Banking on valuation comfort Jyothy Labs: Why the stock is a buy after 30 pc drop in last 1 year What They Say on Their India Plans Who Am I? April 26, 2026 HDFC Bank: Key takeaways for investors from Q4 results Narayana Health: Heart At The Right Place Who Am I? April 19, 2026 Citius TransNet InvIT IPO: Should you apply? What the numbers say The sector call illusion Caplin Point: Consolidating before the next leg of growth Who Am I? April 12, 2026 Banking on a transformation Who Am I? April 5, 2026 Zydus Lifesciences: Bridging the gap What should investors do about Bosch shares New India Assurance stock call: Should investors accumulate on dips? Will this engineering behemoth stock fix the dented investor confidence? Who Am I? March 29, 2026 Equities, Bonds, Commodities, Currencies et al: How They Fare Three Weeks into the US-Iran War Navin Fluorine: What Should You Do? Who Am I? March 22, 2026 HDFC Bank’s Part-time Chairman resigns: What investors need to know CMPDI IPO Review: Subscribe to Central Mine Planning & Design Institute Issue? Who Am I? March 15, 2026 Ambuja Cements: What Should You Do? IHCL stock: Accumulate on dips after correction Raajmarg Infra Investment Trust IPO: Should you invest? AMC stocks defy markets, enjoy outperformance and premium valuations United Breweries Hold Call: Margin Gains Help, But Valuation Remains Rich PG Electroplast stock: Hot Summer, Hotter Sales Who Am I? March 8, 2026 Should you subscribe to Sedemac Mechatronics IPO? Who Am I? March 1, 2026 ITC Hotels: Accumulate on dips as valuation cools and asset-light growth gathers pace Lumax Industries: Should You Book Profit After The Small-Cap’s Stellar Run? What They Say on Their India Plans DLF: A Premium Residential and Commercial Spaces Play Clean Max IPO: Should You Subscribe? Who Am I? Feb 22, 2026 Tata Motors: What investors need to know about the demerged commercial vehicle business Who Am I? Feb 15, 2026 Sun Pharma: What should investors do? What the merger of PFC and REC means for investors India Inc delivers well in Q3 FY26 NBCC: A Solid Construction Play on Government Capex Fractal Analytics IPO review: Valuation looks demanding amid AI disruption Who Am I? Feb 8, 2026 How market fares around Budgets Dr. Reddy and Cipla: Growth in the post-Lenalidomide era for pharma stocks Who Am I? Feb 1, 2026 Who Am I? Jan 25, 2026 Should You Consider Buying Bank of Maharashtra’s Stock? What investors need to glean from HDFC Bank’s Q3 results Neuland Laboratories: What Should Investors Do? Who Am I? Jan 18, 2026 Shadowfax IPO Review: Fast Growth, Thin Margins — Subscribe or Wait? Amagi Media Labs IPO: Are valuations outpacing profits for this SaaS company? Nexus Select Trust: Yielding More on Urban Consumption Who Am I? Jan 11, 2026 BCCL IPO: Cheap on paper, costly in a downcycle; why Coal India may be the smarter pick Mankind Pharma: Finding synergies amidst transformation What Should Investors Do About The PNB Housing Finance Stock? Who Am I? Jan 4, 2026 Chalet Hotels: Buy, Sell or Hold? Shree Cement: What Should Investors Do? Who Am I? Dec 28, 2025 Decoding Life Insurers ICICI Prudential Life: Is The Least Expensive Life Insurer A Good Bet Now?
Kotak Mahindra Bank: Good time to relook?
By Nishanth Gopalakrishnan · 2026-06-07 · via Stocks Fundamentals Analysis India | The HinduBusinessLine

Since our last ‘accumulate’ call on Kotak Mahindra Bank (KMB) in August 2025 at around ₹399 per share, the stock has stayed flat. This is largely to do with the stock’s FY26 financial results, which were ordinary. The profit (before one-offs) of the standalone bank grew 2 per cent over FY25 and that of the group remained flat. This was largely due to margin compression and certain asset-quality issues at the bank. The bank accounts for three-fourths of the consolidated net worth. Net interest margin (NIM) declined from 4.96 per cent for FY25 to 4.6 per cent for FY26. Provisions were elevated and recorded a growth of 18 per cent year on year. Performance of key subsidiaries also was not remarkable enough to write home about.

However, by Q4 FY26, with tighter underwriting, the bank has manoeuvred those asset-quality concerns well and they are largely behind. Collection efficiency has improved in the impacted segments of microfinance, credit cards and retail commercial vehicles and going ahead, the bank is confident to scale these products once again. Asset quality is expected to be stable in FY27, save for any surprises in store, driven by trade disruptions or weather-related causes in SME, agri and tractor finance segments. These portfolios are performing well at the moment, though.

NIM could see slight decline in FY27 too, as the bank is pursuing longer-tenor term deposits at the cost of margin. However, there are a few levers to offset this, as detailed here. The upcoming ECL (expected credit loss) framework from FY28 is likely to impact the bank’s net worth by 2 per cent, per the management.

These meant the group’s price-to-book value (P/B) multiple shrank from 2.5x at the time of our earlier call to about 2.1x now — 1.5 standard deviations below the five-year mean of 3.1x. The accompanying infographic contains the SOTP (sum-of-the-parts) price of the stock, worked with conservative assumptions — a multiple of just 2x has been ascribed for the bank (vs 2.5x in our earlier call). At this price, the stock appears fairly valued. However, going forward, given credit costs could remain benign in the backdrop of good balance sheet momentum, shareholders can expect good book value accretion. Hence long-term investors can accumulate the stock.

FY26 performance

The standalone bank first. In FY26, KMB’s advances grew 16.2 per cent year on year, in-line with the banking system. It gained market share in deposits though, growing at 14.7 per cent, against the system’s 13.5 per cent. CASA balances deserve a mention. They grew 15.5 per cent, higher than private banking peer HDFC’s 12.3 per cent and ICICI’s 10.4 per cent. CASA ratio was resilient at 43.3 per cent vs 43 per cent as of FY25-end.

Most segments of the loan book recorded healthy growth except for three: Unsecured personal loans (3 per cent), credit cards (-8 per cent) and microfinance (-8 per cent). These were the ones with asset-quality concerns as said above and notably, they carry relatively higher yields, padding NIM. They largely form the unsecured book of the bank, which now stands at 8.9 per cent of the loan book from 10.5 per cent, a year ago.

However, things are looking up. The personal loan book has been growing sequentially for the past couple quarters. After quarter-on-quarter (q-o-q) declines in Q1 and Q2 FY26, microfinance book arrested degrowth in Q3 and grew sequentially in Q4. Credit cards shrunk in Q1-Q3, but remained flat in Q4 on a q-o-q basis. The bank had been revamping its credit card line-up and now that it is done, the portfolio is ready for scaling up. Slippages (1.6 per cent of advances in Q1 FY26) and credit cost (0.9 per cent of advances in Q1 FY26) improved through the quarters to healthy levels of 0.8 per cent and 0.4 per cent respectively, as of Q4 FY26. GNPA ratio stands at 1.2 per cent down from 1.4 per cent a year ago. The management is, however, watchful of these segments, in addition to SME, Agri and Tractor finance, as they are the most vulnerable in case of a macro stress.

FY26 standalone profit grew a marginal 2 per cent (before one-offs) and RoA slid to 1.97 per cent from 2.2 per cent in FY25. This was primarily driven by an 18 per cent rise in provisions (largely from unsecured book), loss of fee income from credit cards and NIM compression of about 50 bps (4.6 per cent for FY26 from 4.96 for FY25). KMB’s NIM decline (about 30 bps) is greater than peers HDFC and ICICI, who have gone through this rate transmission cycle with negligible impact on NIMs (Q4 FY26 vs Q3 FY25). Poor growth in the unsecured book is the key reason.

NIM push and pulls

Going into FY27, NIM could further contract but gradually, owing to higher rates offered for longer-tenor term deposits (longer than the bank’s current average tenor of 9-12 months) than competitors. This is KMB’s strategy to navigate the current deposit drought. However, there are levers to offset this. One, the restart in unsecured book could bring in higher yields. Two, good momentum is seen in low-cost CASA deposits as mentioned above. Any increment to the CASA ratio will aid propping margin.

Subsidiaries

A handful of wholly-owned subsidiaries account for the rest of the group’s net worth. Capital market subsidiaries were impacted by FII outflows, geopolitics, trade disruption and a general weakness in the market. Kotak Securities (brokerage) and Kotak Mahindra Capital (investment bank) recorded no profit growth. Kotak AMC managed double-digit profit growth (11 per cent) and an AUM expansion of 22 per cent.

Net profit of vehicle finance subsdiary Kotak Mahindra Prime, too, did not grow owing to marked-to-market losses. Its loan book grew 12 per cent. Life Insurance subsidiary’s embedded value rose 9.2 per cent.

Published on June 6, 2026